Federated Hermes, Inc. Glycomimetics Inc Transaction History

Federated Hermes, Inc.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	SELL	$1.25 - $4.05 $803 - $2,604	-643 Reduced 15.92%	3,395 $4,000
Q4 2022 Feb 13, 2023	SELL	$0.57 - $3.03 $584 - $3,105	-1,025 Reduced 20.24%	4,038 $12,000
Q2 2022 Aug 15, 2022	SELL	$0.54 - $1.15 $114,508 - $243,860	-212,053 Reduced 97.67%	5,063 $3,000
Q1 2022 May 13, 2022	SELL	$1.0 - $1.58 $128,336 - $202,770	-128,336 Reduced 37.15%	217,116 $248,000
Q4 2021 Feb 14, 2022	BUY	$1.44 - $2.14 $1,193 - $1,774	829 Added 0.24%	345,452 $497,000
Q3 2021 Nov 15, 2021	BUY	$1.8 - $2.39 $1,891 - $2,511	1,051 Added 0.31%	344,623 $755,000
Q2 2021 Aug 16, 2021	BUY	$2.16 - $3.18 $2,032 - $2,992	941 Added 0.27%	343,572 $797,000
Q1 2021 May 13, 2021	SELL	$2.89 - $4.22 $203,360 - $296,948	-70,367 Reduced 17.04%	342,631 $1.03 Million
Q4 2020 Feb 12, 2021	SELL	$2.69 - $4.24 $233,806 - $368,528	-86,917 Reduced 17.39%	412,998 $1.55 Million
Q3 2020 Nov 12, 2020	SELL	$3.07 - $5.0 $3,048 - $4,965	-993 Reduced 0.2%	499,915 $1.54 Million
Q2 2020 Aug 13, 2020	BUY	$2.06 - $3.76 $115,914 - $211,571	56,269 Added 12.65%	500,908 $1.88 Million
Q1 2020 May 13, 2020	BUY	$1.83 - $5.41 $561,464 - $1.66 Million	306,811 Added 222.6%	444,639 $1.01 Million
Q4 2019 Feb 14, 2020	BUY	$4.03 - $6.5 $555,446 - $895,882	137,828 New	137,828 $729,000
Q1 2018 May 09, 2018	SELL	$16.06 - $25.35 $14,983 - $23,651	-933 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$10.51 - $17.22 $9,805 - $16,066	933	933 $0

17.8M

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $16.3M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.